ACIU Cash from 2010 to 2025

ACIU Stock  USD 2.16  0.06  2.70%   
AC Immune Cash yearly trend continues to be comparatively stable with very little volatility. Cash will likely drop to about 34.5 M in 2025. Cash is the total amount of money in the form of currency that AC Immune has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2014-12-31
Previous Quarter
32.4 M
Current Value
36.3 M
Quarterly Volatility
63.2 M
 
Yuan Drop
 
Covid
Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Interest Expense of 126.3 K, Selling General Administrative of 8.7 M or Total Revenue of 20.1 M, as well as many indicators such as Price To Sales Ratio of 9.38, Dividend Yield of 0.0 or PTB Ratio of 2.28. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
  
Check out the analysis of AC Immune Correlation against competitors.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

Latest AC Immune's Cash Growth Pattern

Below is the plot of the Cash of AC Immune over the last few years. Cash refers to the most liquid asset of AC Immune, which is listed under current asset account on AC Immune balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from AC Immune customers. The amounts must be unrestricted with restricted cash listed in a different AC Immune account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. AC Immune's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AC Immune's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

ACIU Cash Regression Statistics

Arithmetic Mean73,462,078
Geometric Mean42,042,914
Coefficient Of Variation88.17
Mean Deviation54,633,047
Median76,522,000
Standard Deviation64,770,532
Sample Variance4195.2T
Range190.3M
R-Value0.29
Mean Square Error4104.4T
R-Squared0.09
Significance0.27
Slope4,009,698
Total Sum of Squares62928.3T

ACIU Cash History

202534.5 M
202436.3 M
202378.5 M
202231.6 M
202182.2 M
2020160.9 M
2019193.6 M

Other Fundumenentals of AC Immune

AC Immune Cash component correlations

About AC Immune Financial Statements

AC Immune shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although AC Immune investors may analyze each financial statement separately, they are all interrelated. The changes in AC Immune's assets and liabilities, for example, are also reflected in the revenues and expenses on on AC Immune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash36.3 M34.5 M
Cash And Short Term Investments165.5 M164.7 M
Change In Cash-42.2 M-40.1 M
Free Cash Flow65.3 M68.5 M
Begin Period Cash Flow78.5 M100.1 M
Total Cashflows From Investing Activities21.4 M22.5 M
Other Cashflows From Financing Activities-548 K-520.6 K
Other Non Cash Items1.6 M1.7 M
Total Cash From Operating Activities65.8 M69.1 M
Total Cash From Financing Activities-1.1 M-1.1 M
End Period Cash Flow36.3 M34.5 M
Other Cashflows From Investing Activities-104.7 M-99.5 M
Free Cash Flow Yield 0.24  0.25 
Operating Cash Flow Per Share 0.60  0.63 
Free Cash Flow Per Share 0.59  0.62 
Cash Per Share 1.50  1.60 
Capex To Operating Cash Flow 0.01  0.01 
EV To Operating Cash Flow 3.63  3.81 
EV To Free Cash Flow 3.66  3.84 
Price To Operating Cash Flows Ratio 4.10  4.30 
Price To Free Cash Flows Ratio 4.13  4.34 
Cash Ratio 0.36  0.34 
Cash Conversion Cycle 29.44  27.97 
Operating Cash Flow Sales Ratio 2.41  2.53 
Free Cash Flow Operating Cash Flow Ratio 0.99  1.13 
Cash Flow Coverage Ratios 12.13  12.74 
Price Cash Flow Ratio 4.10  4.30 
Cash Flow To Debt Ratio 12.13  12.74 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.